Prospects Oncology Fund
FACIT’s Prospects Fund is designed to support early stage proof-of-concept (POC) studies within Ontario academic institutions and start-ups that fit with FACIT’s Investment Strategy and have the potential to act as deal flow for the IPDC Fund. Awarded grants typically range between $50,000 and $200,000.
Funding is governed by a research contract which grants certain rights to FACIT. FACIT receives no financial consideration on Prospects grants under $100,000. On grants of $100,000 or more, FACIT receives an option to make an investment at the IPDC level and act as the agent for commercialization. If the option is exercised, funding received from the Prospects grant will be credited towards FACIT's IPDC investment.
How to apply:
The Prospects Fund is accepting pre-submission forms twice yearly on the following dates:
- March 31
- September 30
The pre-submission form can be downloaded here.
Late applications will not be considered.
Selected applicants will then be invited to prepare a Prospects funding application which is subject to due diligence by FACIT.
Select Prospects Funded Projects
Prospects Fund (Other)
Support for the use of Cell-Mate Technology in a clinical trial for the Genome Canada project entitled "Early detection of patients at high risk of esophageal adenocarcinoma".
A proprietary method to manufacture, store and reconstitute monodisperse and size-tunable, lipid-based microbubbles for ultra-low dose, contrast-enhanced ultrasound.
Evaluation of a Nanostring gene expression assay across three centres for its analytical reproducibility and accuracy in potentially guiding the selection of patient-specific therapies for early br
A mobile health application that seeks to merge tracking of patients’ side effects and situations related to cancer treatments with patient-provider communication.